This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sleep Well at Night with the Highest Paying Health Care REIT

Pickett: We expect that Omega will continue to maintain a conservative balance sheet with debt to EBITDA leverage of 4 times to 5 times.

Thomas: Omega has the highest dividend yield (7.7%) in the healthcare sector. In my opinion, partly due to under-valuation and also due to higher risk assets. How would you describe your company's value proposition?

Pickett: I believe that our equity is undervalued. However, the SNF industry is very cyclical, with cycles typically driven by investor views on reimbursement risk. We happen to be in a cycle of high perceived reimbursement risk.

Thomas: Omega has increased its dividend by 14.2% in 2010, 13.1% in 2011, and 9.3% in 2012. Is this growth sustainable?

Pickett: Our investment strategy has remained the same for the last 9 years and we have delivered great financial results. The strategy has not changed and there are many industry opportunities. We are optimistic about our future growth prospects.

Thomas: Do you see trends of skilled nursing customers to transition into in-home services? If so, could this be problematic for your tenants/operators in the future?

Pickett: In-home services have grown dramatically over the last decade. During the decade, SNF occupancy has remained stable, while patient acuity in SNFs has gone up. Our view is that the care delivered in the SNF setting cannot be delivered less expensively in the home. We believe in-home services and SNF care are compatible versus competitive settings.

At the time of publication the author held no positions in any of the stocks mentioned.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
OHI $34.79 0.12%
FB $87.28 0.43%
GOOG $523.40 0.30%
TSLA $280.02 4.04%
YHOO $39.38 0.13%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs